The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Jack Cassel - Nasdaq - Analyst
: Love that. That was great and comprehensive and took a lot of my questions. So we'll have to figure this out. So maybe we'll start off with just kind
of the third quarter trends that we saw. So they, it was great to see the BSI orders increase the MSDs year over year.
And really that increasing sequentially that said you had guided towards lower sales and a lower EPS, a lot of -- the majority of that due to FX.
Maybe let's start there with just kind of framing the Q3 trends and where we go from there.
Question: Jack Cassel - Nasdaq - Analyst
: Okay. And can you remind everybody how you think about orders and how that feeds in revenues and kind of what that timing is?
Question: Jack Cassel - Nasdaq - Analyst
: Okay. And can you talk about timsTOF? A little bit and just that competitive environment and what that's like?
Question: Jack Cassel - Nasdaq - Analyst
: Yeah, you touch upon obviously the acquisitive nature of Bruker and I think you've done about 10 deals or so up until October, I guess, what's your
outlook on remaining inquisitive, and maybe walk us through just kind of how you continue that in organic growth?
Question: Jack Cassel - Nasdaq - Analyst
: Great. I will pause here to see if there's any questions from the audience. We've got one here.
Unidentified Participant
Can I ask you why you think now we are at this important point where finally we got into proteomics. I mean, we saw this year, the Nobel Prize that
went to the Deep Mind team at Google with the AlphaFold. So there is a recognition of the importance of protein, and you have done this investment
well in advance. But what making that now, finally we're going to see (multiple speakers) area of research going?
Question: Jack Cassel - Nasdaq - Analyst
: Great. Any -- we're out of time here, but any other burning last questions before lunch? Cool. All right. Well, with that, we'll conclude.
| 
